1. Lack of Response to Intravitreal Ranibizumab Treatment in Adult Onset Foveomacular Vitelliform Dystrophy Complicated with Choroidal Neovascularization: A Case Report
- Author
-
Berhuni M, Tıskaoğlu NS, and Ozturkmen C
- Subjects
- Humans, Female, Middle Aged, Choroidal Neovascularization drug therapy, Choroidal Neovascularization diagnostic imaging, Antibodies, Monoclonal, Humanized administration & dosage, Ranibizumab administration & dosage, Vitelliform Macular Dystrophy drug therapy, Vitelliform Macular Dystrophy diagnostic imaging, Vitelliform Macular Dystrophy diagnosis, Intravitreal Injections, Angiogenesis Inhibitors administration & dosage
- Abstract
Adult-onset foveomacular vitelliform dystrophy (AOFVD) is a rare disease characterized by accumulation of yellowish deposits in the macula. Rarely, it may be complicated by choroidal neovascularization (CNV). Cases with CNV may be confused with occult CNV in age-related macular degeneration. In our case, we will present the visual and anatomical results of a patient with AOVF-related CNV, in which we administered 3 doses of intravitreal ranibizumab (IVR). A 59-year-old female patient, who attended our clinic with the complaint of decreased vision in both eyes, was diagnosed with AOVF-related CNV in both eyes and was treated with 3 doses of IVR for 3 months. Despite the improvement in visual and anatomical functions 1 month after the first dose, vision decreased, and anatomical functions regressed to the pre-injection state in continued injections. IVR therapy is not an appropriate treatment option in the treatment of AOVF-associated CNV.
- Published
- 2025
- Full Text
- View/download PDF